title: Twenty-two cutaneous primary melanomas in a patient with high genetic predisposition to melanoma receiving levodopa therapy for Parkinson's disease.
authors.forename: Julie
authors.initials: J
authors.lastname: Charles
authors.forename: Isabelle
authors.initials: I
authors.lastname: Templier
authors.forename: Dominique
authors.initials: D
authors.lastname: Leroux
authors.forename: Dimitri
authors.initials: D
authors.lastname: Salameire
authors.forename: Caroline
authors.initials: C
authors.lastname: Robert
authors.forename: Sylvie
authors.initials: S
authors.lastname: Lantuejoul
authors.forename: Marie-Therese
authors.initials: MT
authors.lastname: Leccia
mesh_terms: D004252:DNA Mutational Analysis; D020022:Genetic Predisposition to Disease; D006801:Humans; D007980:Levodopa / Q000009:adverse effects*; D008297:Male; D008545:Melanoma / Q000188:drug therapy* / Q000473:pathology; D008875:Middle Aged; D010300:Parkinson Disease / Q000188:drug therapy*; D012878:Skin Neoplasms / Q000188:drug therapy* / Q000473:pathology; D014466:Ultraviolet Rays / Q000009:adverse effects
chemical_list: D007980:Levodopa